Quick Overview: The panelists share their thoughts on treatment choice in a patient with In this segment, the panelists review the case of a patient with refractory Andrei Gafita, MD, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, discusses the results of the multicenter, ...
Performance Status And Progressive Mcrpc - Detailed Overview & Context
The panelists share their thoughts on treatment choice in a patient with In this segment, the panelists review the case of a patient with refractory Andrei Gafita, MD, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, discusses the results of the multicenter, ... A regional roundtable discussion, moderated by Chandler Park, MD, Norton Cancer Institute, focused on evolving strategies in ... The tolerability of I/O-I/O combination therapy in frontline NSCLC is examined, including for patients with poor Raoul Concepcion, MD, director, Comprehensive Prostate Center, discussed the best treatment option for a patient with metasatic ...
Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses the importance of ... A regional roundtable discussion, moderated by Jason Hafron, MD, Michigan Institute of Urology, focused on the diagnostic and ... Przemyslaw W. Twardowski, MD, director, Prostate Oncology Strategic Program, director, Genitourinary Program, clinical ... Richard Cathomas, MD, PhD, Hospital Graubünden, Chur, Switzerland, talks on treatment strategies for patients with ... Scott T. Tagawa, MD, MS, Weill Cornell Medical College, New York Presbyterian Hospital, NY, discusses the results of a ... Nicholas Vogelzang, MD, and Daniel Petrylak, MD, review the importance of tailoring therapy for advanced
Nicolas Sayegh, MD, University of Utah, Salt Lake City, UT, details the results of a retrospective study evaluating overall survival ... Case-Based Peer Perspectives in CRC: For more ... In this segment, the panelists discuss their approach to a patient with asymptomatic, non-metastatic castration-resistant Rana R. McKay, MD, argues for increased treatment of This focused session addresses optimal treatment strategies for patients with left main and complex bifurcation coronary lesions. Daniel J. George, MD, highlights emerging trials such as PEACE III that further explore the use of radium-223 in
Howard Scher, MD, FASCO, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the development and validation ... Richard Simcock, MBBS, MCRP, FRCR, Brighton and Sussex University Hospital NHS Trust, Sussex, UK, highlights the ...
